Altshuler Shaham’s Stoke Therapeutics STOK Stock Holding History

Altshuler Shaham’s Portfolio STOK Stock Details STOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-1,234	Closed	-$35K	–	598
2019 Q4	$35K	Buy	+1,234	New	+$31K	﹤0.01%	203

Other funds holding STOK

ALSV

ATP Life Science Ventures New York $898M AUM 84.86% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Altshuler Shaham's STOK Position: Q1 2020 in Review

Altshuler Shaham sold out of Stoke Therapeutics (STOK) in Q1 2020, closing a stake of 1,234 shares — an estimated $35K sold.

Altshuler Shaham first reported a position in STOK in Q4 2019 and held it in 1 quarter. The position peaked at $35K in Q4 2019. 67 funds tracked by Wall St. Rank hold STOK as of Q1 2020.

Altshuler Shaham reported no remaining Stoke Therapeutics position as of Q1 2020 after selling out during the quarter.
Altshuler Shaham sold 1,234 Stoke Therapeutics shares in Q1 2020, an estimated $35K.
Altshuler Shaham first reported a position in Stoke Therapeutics in Q4 2019 and held it in 1 quarter.
Altshuler Shaham's Stoke Therapeutics position peaked at $35K in Q4 2019.
67 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q1 2020.

Based on Altshuler Shaham's 13F filing for Q1 2020, filed 12 May 2020.